Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy
Abstract Somatic genetic alteration analysis was performed for post-hysterectomy high-risk early-stage uterine cervical cancer patients who underwent post-operative radiation therapy. Post-operative radiation therapy was performed for patients with pathological features of pelvic lymph node metastas...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/cda706406e7644d5a5156ae569f6d36b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:cda706406e7644d5a5156ae569f6d36b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:cda706406e7644d5a5156ae569f6d36b2021-12-02T15:45:27ZDistribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy10.1038/s41598-021-90139-02045-2322https://doaj.org/article/cda706406e7644d5a5156ae569f6d36b2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90139-0https://doaj.org/toc/2045-2322Abstract Somatic genetic alteration analysis was performed for post-hysterectomy high-risk early-stage uterine cervical cancer patients who underwent post-operative radiation therapy. Post-operative radiation therapy was performed for patients with pathological features of pelvic lymph node metastasis, parametrium invasion, or positive vaginal margin, which corresponded to the post-operative high-risk category. DNA was extracted from paraffin-embedded surgical specimens, and 50 somatic hotspot genetic alternations were detected using Ion AmpliSeq Cancer Hotspot Panel. The existence of actionable mutation was assessed based on OncoKB evidence level > 3A. Between January 2008 and November 2019, 89 patients who underwent abdominal radical hysterectomy followed by post-operative radiation therapy were identified. The follow-up period for living patients was 82.3 months (range 9.3–153.9), and the 5-year relapse-free survival and overall survival rates were 72.6% and 85.9%, respectively. The most frequently detected somatic mutation was PIK3CA (26 [29.2%] patients); however, no prognostic somatic genetic alterations were identified. Actionable mutations were detected in 30 (33.7%) patients. Actionable mutations were detected in approximately one-third of patients, suggesting that precision medicine can be offered to patients with post-operative high-risk uterine cervical cancer in the near future.Naoya MurakamiYuka AsamiHiroshi YoshidaDaisuke TakayanagiSou HiroseIkumi KunoKazuaki TakahashiMaiko MatsudaYoko ShimadaShotaro YamanoKuniko SunamiTakayuki HondaTomomi NakaharaTomoko WatanabeKae OkumaTakafumi KurodaTakashi KohnoTomoyasu KatoKouya ShiraishiJun ItamiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Naoya Murakami Yuka Asami Hiroshi Yoshida Daisuke Takayanagi Sou Hirose Ikumi Kuno Kazuaki Takahashi Maiko Matsuda Yoko Shimada Shotaro Yamano Kuniko Sunami Takayuki Honda Tomomi Nakahara Tomoko Watanabe Kae Okuma Takafumi Kuroda Takashi Kohno Tomoyasu Kato Kouya Shiraishi Jun Itami Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy |
| description |
Abstract Somatic genetic alteration analysis was performed for post-hysterectomy high-risk early-stage uterine cervical cancer patients who underwent post-operative radiation therapy. Post-operative radiation therapy was performed for patients with pathological features of pelvic lymph node metastasis, parametrium invasion, or positive vaginal margin, which corresponded to the post-operative high-risk category. DNA was extracted from paraffin-embedded surgical specimens, and 50 somatic hotspot genetic alternations were detected using Ion AmpliSeq Cancer Hotspot Panel. The existence of actionable mutation was assessed based on OncoKB evidence level > 3A. Between January 2008 and November 2019, 89 patients who underwent abdominal radical hysterectomy followed by post-operative radiation therapy were identified. The follow-up period for living patients was 82.3 months (range 9.3–153.9), and the 5-year relapse-free survival and overall survival rates were 72.6% and 85.9%, respectively. The most frequently detected somatic mutation was PIK3CA (26 [29.2%] patients); however, no prognostic somatic genetic alterations were identified. Actionable mutations were detected in 30 (33.7%) patients. Actionable mutations were detected in approximately one-third of patients, suggesting that precision medicine can be offered to patients with post-operative high-risk uterine cervical cancer in the near future. |
| format |
article |
| author |
Naoya Murakami Yuka Asami Hiroshi Yoshida Daisuke Takayanagi Sou Hirose Ikumi Kuno Kazuaki Takahashi Maiko Matsuda Yoko Shimada Shotaro Yamano Kuniko Sunami Takayuki Honda Tomomi Nakahara Tomoko Watanabe Kae Okuma Takafumi Kuroda Takashi Kohno Tomoyasu Kato Kouya Shiraishi Jun Itami |
| author_facet |
Naoya Murakami Yuka Asami Hiroshi Yoshida Daisuke Takayanagi Sou Hirose Ikumi Kuno Kazuaki Takahashi Maiko Matsuda Yoko Shimada Shotaro Yamano Kuniko Sunami Takayuki Honda Tomomi Nakahara Tomoko Watanabe Kae Okuma Takafumi Kuroda Takashi Kohno Tomoyasu Kato Kouya Shiraishi Jun Itami |
| author_sort |
Naoya Murakami |
| title |
Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy |
| title_short |
Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy |
| title_full |
Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy |
| title_fullStr |
Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy |
| title_full_unstemmed |
Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy |
| title_sort |
distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/cda706406e7644d5a5156ae569f6d36b |
| work_keys_str_mv |
AT naoyamurakami distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT yukaasami distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT hiroshiyoshida distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT daisuketakayanagi distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT souhirose distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT ikumikuno distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT kazuakitakahashi distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT maikomatsuda distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT yokoshimada distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT shotaroyamano distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT kunikosunami distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT takayukihonda distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT tomominakahara distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT tomokowatanabe distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT kaeokuma distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT takafumikuroda distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT takashikohno distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT tomoyasukato distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT kouyashiraishi distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy AT junitami distributionofgeneticalterationsinhighriskearlystagecervicalcancerpatientstreatedwithpostoperativeradiationtherapy |
| _version_ |
1718385777366269952 |